E2F3 and non-small cell lung carcinoma: While searching for the putative targets of miR-125b-5p using a bioinformatics approach, we identified a potential binding site between miR-125b-5p and E2F3 (Figure 6A), which was selected for the subsequent experiments to determine the role of E2F3 in affecting NSCLC malignancy [22, 23].